Neurotech International Ltd
ASX:NTI
Neurotech International Ltd
ASX:NTI
Price:
0.078 AUD
4%
Market Closed
Updated:
May 16, 2024
Neurotech International Ltd
Cash from Financing Activities
|
Neurotech International Ltd
Cash from Financing Activities Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Financing Activities
AU$28m
|
CAGR 3-Years
3%
|
CAGR 5-Years
192%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
2%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$377.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-21%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Financing Activities
AU$16.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
140%
|
CAGR 10-Years
54%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$2.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Neurotech International Ltd's Cash from Financing Activities?
Cash from Financing Activities
9.4m
AUD
9.4m
AUD
Based on the financial report for Dec 31, 2023, Neurotech International Ltd's Cash from Financing Activities amounts to 9.4m AUD.
What is Neurotech International Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
47%
47%
Over the last year, the Cash from Financing Activities growth was 3%. The average annual Cash from Financing Activities growth rates for Neurotech International Ltd have been 47% over the past three years .
You don't have any saved screeners yet
